Navigation Links
Lead Trial Attorney in Clark County Hepatitis C Trial, Robert Eglet, Asks Jury to Award $10 Million Compensatory Damages for Anne Arnold, $2.5 Million for James Arnold
Date:10/6/2011

LAS VEGAS, Oct. 6, 2011 /PRNewswire/ -- This is being released by SCM:

(Photo:  http://photos.prnewswire.com/prnh/20111006/LA81891)

After 7 weeks of testimony and 4 hours of closing statements, lead trial attorney for the plaintiffs in the hepatitis C trial in Clark County Nevada, Robert Eglet, asked jurors to bring a verdict of $10 million in compensatory damages for Anne Arnold, $2.5 million in compensatory damages for James Arnold and to consider whether the Arnolds should receive punitive damages. 

Attorney Robert Eglet told jurors, corporate greed dictated the actions of the drug company Teva Pharmaceuticals. "The primary concern should be the safety of the patient. A responsible drug company should design, package and market the drug to reduce human error. The drug companies knew there was a problem with the jumbo infusion 50mL vials of Propofol in these endoscopy centers," said Eglet.

Eglet told jurors that every 50mL vial of Propofol was sent to the endoscopy centers with a vent spike labeled for multi dosing.  "The temptation and opportunity is too great for misuse and the drug company knew this. They took no steps to prevent this. They did nothing and Teva expert witnesses Craig Lea and Rosalie Lowe in depositions agreed that health care providers using 50mL vials in an endoscopy center create more of a proclivity to multi dose," said Eglet.  

Attorney Robert Eglet told the jury that production of the sedative Propofol was stopped within 3 weeks of the unprecedented $500 million verdict in the Chanin trial in May 2010. Teva Vice President, Craig Lea admitted under examination by Eglet that Teva turned the lights out in their Propofol plant 21 days after last year's verdict. 

The jury is now in deliberation.

Plaintiff Anne Arnold was exposed to the virus hepatitis C when a contaminated jumbo 50mL infusion vial o
'/>"/>

SOURCE SCM
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... SACRAMENTO, Calif. , May 29, 2015  Anpac ... Dr. Chris Yu and the Anpac research ... Summit on Biomedical Science (NPLS) organizers published as, "game ... at the American Society of Clinical Oncology (ASCO) Annual ... 29 – June 2, 2015. An ...
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced the ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... players in the industry are GE , Hitachi Medical ... Systems MRI is a powerful ... higher sensitivity and use of non-ionizing radiations. Open MRI ...
(Date:5/29/2015)... Massachusetts and SPARTANBURG, South Carolina ... The Guardian Research Network and Molecular Health have announced ... and molecular diagnostic decision support to the majority of ... Guardian Research Network will collaborate with Molecular Health to ... testing to identify cohorts from hundreds of thousands of ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... (Nasdaq: MASI ) announced today ... Anesthesia & Analgesia shows that clinicians using ... management and reduced lactate levels in patients during and ... without PVI(1).  Multiple previous studies(2,3,4) have shown that PVI ...
... Prototype of the World,s First Ever... -- JERUSALEM, August 31, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
Cached Medicine Technology:Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery 2Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery 3Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery 4Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery 5Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery 6Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 2Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 3Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 4Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 5Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 6Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 7
(Date:5/29/2015)... May 29, 2015 On May 21, 2015, ... be When You Get Botox ?” reported on the ... Google. Elle partnered with Google to determine these results and ... searched question in California, for example, is how to ... common search query is what's the appropriate age to start ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, yet ... does no wrong. , It’s fitting, then, that her new ... “God Does No Wrong.” It focuses on what happens when ... , “My story has a positive message about channeling the ... something healing,” Howse said. , “God Does No Wrong” immortalizes ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
(Date:5/29/2015)... 2015 A group of doctors have discovered ... national effort to teach this “new math” to children in ... been “sickened” by the recent implementation of Common Core Math ... it, Common Core is now a reality in children’s classrooms ... are now seeking ways to improve common core math training ...
(Date:5/29/2015)... Clearwater, FL (PRWEB) May 29, 2015 ... City, Utah, recently partnered with Stratus ... services, which will facilitate better communication and ... proficiency (LEP) and hearing loss. Stratus’ video ... Healthcare’s in-house translators, enabling staff to quickly ...
Breaking Medicine News(10 mins):Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... 16 (HealthDay News) -- Large differences exist in the levels ... the United States and other developed countries, a new study ... 2,100 food items in seven product categories sold by Burger ... Subway in the United States, Canada, Australia, France, New Zealand ...
... to be rising, especially among high school students, according ... alarming and indicates more coaches and athletic trainers should ... game, according to researchers based at the University of ... number of football-related brain injuries with permanent disability in ...
... share the latest clinical research with addiction treatment ... the April 19th Blending Conference in Atlanta, Georgia. ... on Drug Abuse (NIDA), part of the National ... Society of Addiction Medicine Annual Medical-Scientific Conference as ...
... To relieve pain, arthritis sufferers are prescribed medications ... cyclooxygenase-2 (COX-2) inhibitors, both of which can irritate ... co-prescribed with NSAIDs or COX-2 inhibitors to prevent ... available today in the American College of Rheumatology ...
... 14 (HealthDay News) -- Watching sad movies makes people happier ... a new study finds. "Tragic stories often focus on ... about their loved ones and count their blessings," lead author ... University in Columbus, said in a university news release. ...
... -- A moderate "red tide" is expected in New England ... shellfish beds, according to experts. A red tide is ... water don,t pose a direct threat to people, but toxins ... and cause paralytic shellfish poisoning in people who eat them. ...
Cached Medicine News:Health News:Fast Food Is Saltier in U.S. Than Overseas 2Health News:Football-related catastrophic brain injuries on the rise 2Health News:Football-related catastrophic brain injuries on the rise 3Health News:Not taking gastroprotective drugs prescribed with anti-inflammatory medicines 2Health News:'Red Tide' Likely in New England This Season, Experts Warn 2
Effective adhesive, may be removed from plate without residue. Transparent film for easy visual monitoring of samples...
Adhesive tape sheets for sealing multiwell plates and blocks;...
... ThermalSeal is the only polypropylene based, ... it was developed with the assistance of ... applications. ThermalSeal prevents vapor loss and ... +125C at 75% humidity. It can ...
... is the only polypropylene based, pressure resistant, ... developed with the assistance of a major ... ThermalSeal prevents vapor loss and is thermostable ... 75% humidity. It can be used ...
Medicine Products: